Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 4,686 | 9,066 | 3,151 | 3,161 | 2,468 |
| Cost of Goods | 5,173 | 5,077 | 3,715 | 4,120 | 3,780 |
| Gross Profit | -487 | 3,989 | -564 | -960 | -1,310 |
| Operating Expenses | 2,772 | 2,542 | 3,342 | 4,180 | 3,130 |
| Operating Income | -3,086 | 1,524 | -3,191 | -5,019 | -3,662 |
| Interest Expense | 966 | 993 | 901 | 20 | 1,010 |
| Other Income | -72 | 118 | 10 | -3,061 | 2 |
| Pre-tax Income | -4,124 | 649 | -4,082 | -8,100 | -4,670 |
| Income Tax | N/A | -296 | N/A | 0 | 0 |
| Net Income Continuous | -4,124 | 945 | -4,082 | -8,105 | -4,672 |
| Net Income | $-4,124 | $945 | $-4,082 | $-8,105 | $-4,672 |
| EPS Basic Total Ops | -14.00 | 3.50 | -14.00 | -28.00 | -16.50 |
| EPS Basic Continuous Ops | -14.22 | 3.27 | -13.94 | -28.16 | -16.27 |
| EPS Diluted Total Ops | -14.00 | 3.50 | -14.00 | -28.00 | -16.50 |
| EPS Diluted Continuous Ops | -14.22 | 3.27 | -13.94 | -28.16 | -16.27 |
| EBITDA(a) | $-2,264 | $2,297 | $-2,394 | $-3,259 | $-3,342 |